Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:
NovoCure Limited - Ordinary Shares   (ticker: NVCR)
Insiders' Indicator :          Hold          (Click Here For Details)
INSIDERS' Score: 40
0 100 40
BuySell
Latest 1 month: 0 0
Latest 6 Months: 0 336,477
52 Weeks: 0 718,118
Details Of Insider Trading Activities
TransactionCompanyTickerInsiderShares TradedAvg.
Price
Total ValueFiling
2021-04-01
Sale
NovoCure LtdNVCRDOYLE WILLIAM F
Executive Chairman, Director
7,928$134.12$1,063,303
2021-03-09
Sale
NovoCure LtdNVCRShah Pritesh
Chief Commercial Officer
3,524$131.09$461,961
2021-03-08
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
3,004$130.81$392,953
2021-03-08
Sale
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
765$130.81$100,069
2021-03-08
Sale
NovoCure LtdNVCRLongsworth Todd Christopher
General Counsel
2,404$130.81$314,467
2021-03-08
Sale
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
765$130.81$100,069
2021-03-08
Sale
NovoCure LtdNVCRShah Pritesh
Chief Commercial Officer
2,627$130.81$343,637
2021-03-05
Sale
NovoCure LtdNVCRBenaim Ely
Chief Medical Officer
2,918$131.53$383,804
2021-03-05
Sale
NovoCure LtdNVCRShah Pritesh
Chief Commercial Officer
4,550$131.53$598,461
2021-03-04
Sale
NovoCure LtdNVCRShah Pritesh
Chief Commercial Officer
2,658$137.55$365,607
2021-03-04
Sale
NovoCure LtdNVCRBenaim Ely
Chief Medical Officer
1,888$137.55$259,694
2021-03-04
Sale
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
567$137.55$77,990
2021-03-04
Sale
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
567$137.55$77,990
2021-03-04
Sale
NovoCure LtdNVCRLongsworth Todd Christopher
General Counsel
3,084$137.55$424,204
2021-03-04
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
3,854$137.55$530,117
2021-03-03
Sale
NovoCure LtdNVCRShah Pritesh
Chief Commercial Officer
2,174$150.78$327,795
2021-03-03
Sale
NovoCure LtdNVCRBenaim Ely
Chief Medical Officer
3,475$150.78$523,960
2021-03-02
Sale
NovoCure LtdNVCRLongsworth Todd Christopher
General Counsel
2,355$152.05$358,077
2021-03-02
Sale
NovoCure LtdNVCRShah Pritesh
Chief Commercial Officer
912$152.05$138,669
2021-03-02
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
2,392$152.05$363,703
2021-03-02
Sale
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
428$152.05$65,077
2021-03-02
Sale
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
430$152.05$65,381
2021-02-22
Sale
NovoCure LtdNVCRWeinberg Uri
Chief Science Officer
6,500$175.50$1,140,750
2021-01-15
Sale
NovoCure LtdNVCRLongsworth Todd Christopher
General Counsel
63,814$172.48$11,006,638
2020-12-21
Sale
NovoCure LtdNVCRBenaim Ely
Chief Medical Officer
2,484$156.71$389,267
2020-12-18
Sale
NovoCure LtdNVCRDanziger Asaf
Chief Executive Officer, Director
207,910$157.39$32,722,954
2020-12-18
Sale
NovoCure LtdNVCRHILLEMAN JERYL L
Director
2,500$166.40$416,000
2020-11-02
Sale
NovoCure LtdNVCRCordova Ashley
Chief Financial Officer
230$117.41$27,004
2020-09-25
Sale
NovoCure LtdNVCRWeinberg Uri
Chief Science Officer
15,250$103.35$1,576,087
2020-09-18
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
8,262$109.21$902,293
2020-09-17
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
12,500$108.60$1,357,500
2020-09-16
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
22,012$107.35$2,362,988
2020-09-15
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
50,868$103.27$5,253,138
2020-09-15
Sale
NovoCure LtdNVCRLEUNG GABRIEL
Director
9,565$100.00$956,500
2020-09-15
Sale
NovoCure LtdNVCRDanziger Asaf
Chief Executive Officer, Director
103,000$99.00$10,197,000
2020-09-14
Sale
NovoCure LtdNVCRGROENHUYSEN WILHELMUS CM
Chief Operating Officer
25,000$98.01$2,450,250

1 2 3 4 5 6 7 8 9 10 Next >

*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*